- Home
- AGEN vs CFSB Comparison
AGEN vs CFSB Comparison
Compare AGEN & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- CFSB
- Stock Information
- Founded
- AGEN 1994
- CFSB 1889
- Country
- AGEN United States
- CFSB United States
- Employees
- AGEN N/A
- CFSB N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- CFSB Major Banks
- Sector
- AGEN Health Care
- CFSB Finance
- Exchange
- AGEN Nasdaq
- CFSB Nasdaq
- Market Cap
- AGEN 52.6M
- CFSB 51.6M
- IPO Year
- AGEN 2000
- CFSB N/A
- Fundamental
- Price
- AGEN $3.47
- CFSB $7.91
- Analyst Decision
- AGEN Buy
- CFSB
- Analyst Count
- AGEN 4
- CFSB 0
- Target Price
- AGEN $8.33
- CFSB N/A
- AVG Volume (30 Days)
- AGEN 1.0M
- CFSB 1.3K
- Earning Date
- AGEN 05-12-2025
- CFSB 04-29-2025
- Dividend Yield
- AGEN N/A
- CFSB N/A
- EPS Growth
- AGEN N/A
- CFSB N/A
- EPS
- AGEN N/A
- CFSB N/A
- Revenue
- AGEN $99,524,000.00
- CFSB $7,484,000.00
- Revenue This Year
- AGEN $14.67
- CFSB N/A
- Revenue Next Year
- AGEN N/A
- CFSB N/A
- P/E Ratio
- AGEN N/A
- CFSB N/A
- Revenue Growth
- AGEN N/A
- CFSB N/A
- 52 Week Low
- AGEN $1.38
- CFSB $6.34
- 52 Week High
- AGEN $19.69
- CFSB $8.28
- Technical
- Relative Strength Index (RSI)
- AGEN 67.96
- CFSB 52.35
- Support Level
- AGEN $2.83
- CFSB $7.90
- Resistance Level
- AGEN $4.06
- CFSB $8.05
- Average True Range (ATR)
- AGEN 0.34
- CFSB 0.08
- MACD
- AGEN 0.04
- CFSB -0.01
- Stochastic Oscillator
- AGEN 58.74
- CFSB 24.00
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.